Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131857) titled 'A Single-Center, Prospective, Non-Interventional Observational Study of Bevacizumab-Containing Regimens Combined with Hyperthermia for Multiple Cancer Types' on Sept. 7.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: People's Hospital of Zhengzhou

Condition: Non-squamous non-small cell lung cancerns,Ovarian cancer, Colorectal cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-07

Target Sample Size: Observation group (receive treatment with bevacizumab combined with hyperthermia):60;

Countries of Recruitment: China

To know more, visi...